Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, July 21, 2022
[ Thu, Jul 21st 2022
] - WOPRAI
[ Thu, Jul 21st 2022
] - WOPRAI
[ Thu, Jul 21st 2022
] - WOPRAI
[ Thu, Jul 21st 2022
] - WOPRAI
[ Thu, Jul 21st 2022
] - WOPRAI
[ Thu, Jul 21st 2022
] - WOPRAI
[ Thu, Jul 21st 2022
] - WOPRAI
[ Thu, Jul 21st 2022
] - WOPRAI
[ Thu, Jul 21st 2022
] - WOPRAI
[ Thu, Jul 21st 2022
] - WOPRAI
[ Thu, Jul 21st 2022
] - WOPRAI
[ Thu, Jul 21st 2022
] - WOPRAI
[ Thu, Jul 21st 2022
] - WOPRAI
[ Thu, Jul 21st 2022
] - WOPRAI
[ Thu, Jul 21st 2022
] - WOPRAI
[ Thu, Jul 21st 2022
] - WOPRAI
[ Thu, Jul 21st 2022
] - WOPRAI
[ Thu, Jul 21st 2022
] - WOPRAI
[ Thu, Jul 21st 2022
] - WOPRAI
[ Thu, Jul 21st 2022
] - WOPRAI
[ Thu, Jul 21st 2022
] - WOPRAI
[ Thu, Jul 21st 2022
] - WOPRAI
[ Thu, Jul 21st 2022
] - WOPRAI
[ Thu, Jul 21st 2022
] - WOPRAI
[ Thu, Jul 21st 2022
] - WOPRAI
[ Thu, Jul 21st 2022
] - WOPRAI
[ Thu, Jul 21st 2022
] - WOPRAI
Tessa Romero Initiated (XENE) at Buy and Held Target at $55 on, Jul 21st, 2022
Tessa Romero of JP Morgan, Initiated "Xenon Pharmaceuticals Inc." (XENE) at Buy and Held Target at $55 on, Jul 21st, 2022.
Tessa has made no other calls on XENE in the last 4 months.
There are 2 other peers that have a rating on XENE. Out of the 2 peers that are also analyzing XENE, 0 agree with Tessa's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Tessa
- Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $41 on, Monday, June 27th, 2022
- Brian Abrahams of "RBC Capital" Maintained at Buy with Decreased Target to $41 on, Wednesday, May 11th, 2022
